Caverject (Alprostadil) - Summary

CAVERJECT SUMMARY

CAVERJECT contains alprostadil as the naturally occurring form of prostaglandin E₁(PGE₁).

CAVERJECT (CAVERJECT IMPULSE, CAVERJECT Sterile Powder, and CAVERJECT Injection) is indicated for the treatment of erectile dysfunction due to neurogenic, vasculogenic, psychogenic, or mixed etiology.

Intracavernosal CAVERJECT is also indicated as an adjunct to other diagnostic tests in the diagnosis of erectile dysfunction.

CAVERJECT NEWS HIGHLIGHTS

Published Studies Related to Caverject (Alprostadil)

Injection therapy for the treatment of erectile dysfunction: a comparison between alprostadil and a combination of vasoactive intestinal polypeptide and phentolamine mesilate. [2007.10]

Effects of pentoxifylline and alprostadil on ocular hemodynamics in healthy humans. [2007.02]

[Intraurethrally applicated alprostadil for the treatment of organic erectile dysfunction in practice: a multicenter clinical monitoring study (noninterventional investigation)] [2007]

An integrated analysis of alprostadil topical cream for the treatment of erectile dysfunction in 1732 patients. [2006.08]

Topical alprostadil (PGE1) for the treatment of female sexual arousal disorder: in-clinic evaluation of safety and efficacy. [2006.03]

more>>

Clinical Trials Related to Caverject (Alprostadil)

Inhaled PGE1 in Neonatal Hypoxemic Respiratory Failure [Recruiting]

Alprostadil in Macular Degeneration Study (AIMS) [Recruiting]

Alprostadil in PAOD Stage IV [Recruiting]

Prostaglandin E1 (Liprostin) Treatment With Lower Limb Angioplasty for Peripheral Arterial Occlusive Disease [Recruiting]

Sildenafil and Alprostadil in Treating Patients Undergoing Bilateral Nerve-Sparing Robotic-Assisted Prostatectomy for Nonmetastatic Prostate Cancer [Recruiting]

more>>